Clinical Trial Update: Addition of Quetiapine in Obsessive Compulsive Disorder - Westenberg Study [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the addition of quetiapine for obsessive-compulsive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Quetiapine (quetiapine)

Snippet

Sponsor: AstraZeneca | Conditions: Obsessive Compulsive Disorder | Phase 2 | Status: COMPLETED